Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

3805 - Proteomics-based system biology analyses unravel a functional structure with prognostic value


10 Oct 2016


Poster display


Guillermo De Velasco


Annals of Oncology (2016) 27 (6): 1-14. 10.1093/annonc/mdw362


G. De Velasco1, L. Trilla-Fuertes2, A. Gámez-Pozo2, M. Urbanowicz3, G. Ruiz-Ares1, J.M. Sepulveda1, R. Manneh1, B. Homet1, I. Otero1, P. Celiz1, F. Villacampa4, L. Paz-Ares1, J. Fresno Vara2, D. Castellano1

Author affiliations

  • 1 Medical Oncology, Hospital Universitario Doce de Octubre, 28041 - Madrid/ES
  • 2 Molecular Oncology And Pathology Lab, Instituto de Investigación Hospital Universitario La Paz, 28046 - Madrid/ES
  • 3 Pathology, Hospital Universitario Doce de Octubre, 28041 - Madrid/ES
  • 4 Urology, Hospital Universitario Doce de Octubre, 28041 - Madrid/ES


Abstract 3805


Urothelial cancer has been traditionally classified based on histology features. Recently, some works have proposed a molecular classification of muscle-invasive urothelial carcinoma (MIUC) into basal and luminal subtypes. We aimed to define molecular subtypes of MIUC and evaluate the status of several biological processes in the tumor tissue and address its clinical value.


Tissue samples were obtained from 57 pts who underwent curative surgical resection at “Universitary Hospital 12 Octubre” between 2006/12. We analyzed the proteome applying a high-throughput proteomics approach to routinely archive FFPE tumor tissue. Tryptic digests were analyzed by mass spectrometry for protein identification using a Q-Exactive mass spectrometer. Subgroups were defined by hierarchical clustering and random forest. Functional structure was developed using probabilistic graphical models with local minimum Bayesian Information Criterion and Gene Ontology Analysis. Data analysis was done using MeV, BRBArray Tools, R and Cytoscape software suites and Uniprot (http://www.uniprot.org/) and DAVID (http://david.abcc.ncifcrf.gov) webtools.


We identified two different molecular subgroups with differential prognosis. Systems biology analyses showed that wide protein expression assessment allows building a functional structure where several nodes with defined biological activity were defined. Activity measurement for each node showed differences between two subtypes in metabolism, focal adhesion, RNA and splicing nodes. Subtypes defined by protein expression are comparable to basal and luminal subtypes defined by gene expression. Moreover, the focal adhesion node has prognostic value in the whole population, and this prognostic information is independent from a predefined prognostic signature (submitted Abstract: Proteomics profile profiling predicts poor prognosis in patients with muscle invasive urothelial carcinoma).


Protein data analysis using random forest showed subgroups matching with basal and luminal subtypes obtained by hierarchical cluster analysis. Importantly, we were able to establish different nodes according to biological functions, with diagnostic and prognostic value.

Clinical trial identification

Legal entity responsible for the study

Research Institute i + 12


Fundacion Mutual Madrilen.


G. De Velasco: Advisory board for Pfizer. No Conflict of interest with the abstract submitted.

All other authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings